2020
DOI: 10.1039/d0lc00263a
|View full text |Cite|
|
Sign up to set email alerts
|

A bespoke microfluidic pharmacokinetic compartment model for drug absorption using artificial cell membranes

Abstract: A new type of pharmacokinetic compartment model using artificial cell membranes that predicts intestinal absorption three times more accurately than the current state of the art.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 16 publications
(33 citation statements)
references
References 59 publications
0
33
0
Order By: Relevance
“…DIBs present another advantage as they form asymmetric membranes in a simple yet controllable manner by dispersing different lipid mixtures in each droplet [ 138 , 139 ]. Furthermore, these emulsion systems allow for the assembly of membranous networks for investigating synthetic tissues [ 140 ] and bespoke model environment for studying transmembrane exchanges [ 141 ].…”
Section: Model Membranes: Manufactures and Resulting Propertiesmentioning
confidence: 99%
“…DIBs present another advantage as they form asymmetric membranes in a simple yet controllable manner by dispersing different lipid mixtures in each droplet [ 138 , 139 ]. Furthermore, these emulsion systems allow for the assembly of membranous networks for investigating synthetic tissues [ 140 ] and bespoke model environment for studying transmembrane exchanges [ 141 ].…”
Section: Model Membranes: Manufactures and Resulting Propertiesmentioning
confidence: 99%
“…Recently, this approach was revisited to enable the formation of a line of three droplets, with different aqueous environments representing the intestinal lumen, the enterocyte cytoplasm, and the blood lumen ( Figure 12 ). Transport kinetics of fluorescein from intestine to enterocyte to blood droplet compartments could be monitored directly in the microfluidic device using fluorescence microscopy [ 137 ].…”
Section: On-chip Analysis Of Food Dropletsmentioning
confidence: 99%
“…Reprinted from [ 134 ] with permission from Elsevier. Bottom: Microfluidic device for the analysis of bioactive compound transport kinetics between aqueous droplets, as designed in [ 137 ]. Image courtesy of Katherine Elvira, University of Victoria, Canada.…”
Section: Figurementioning
confidence: 99%
“…The integration of these types of technologies into the discovery process is more straightforward since they provide information that can then be verified using mechanisms that are approved as part of The top-left image shows the artificial cells that can be used to form a new type of in vitro pharmacokinetic compartment model using droplets to determine drug behavior early in the discovery process. Reproduced from [53], with permission from the Royal Society of Chemistry. The top-right image shows the design of the microfluidic device for combinatorial drug screening on patient-derived samples using droplets.…”
Section: Microfluidic Technologies For Personalized Medicinementioning
confidence: 99%
“…The hypothesis is that biomimetic tests that can be used early in the discovery process would help to select lead candidates with a greater degree of confidence regarding their future in vivo behavior. We have developed a microfluidic device to build bespoke artificial cells from the bottom up for use as a new type of pharmacokinetic compartment model for intestinal epithelial permeability [53] (Figure 1). In this work, we used a droplet-based PDMS device to model the path that a drug proxy takes from the intestine into an enterocyte (cells that line the intestine) and then into the bloodstream.…”
Section: Microfluidic Platforms For the Creation Of Artificial Cells And Tissuesmentioning
confidence: 99%